NCT01227135View on ClinicalTrials.gov

Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia

PHASE2UnknownINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

March 31, 2012

Conditions
Leukemia
Interventions
DRUG

hydroxychloroquine

DRUG

imatinib mesylate

GENETIC

cytogenetic analysis

GENETIC

polymerase chain reaction

OTHER

laboratory biomarker analysis

OTHER

pharmacological study

Trial Locations (3)

L7 8XP

RECRUITING

Royal Liverpool University Hospital, Liverpool

W12 0HS

RECRUITING

Imperial College London, London

G12 0YN

RECRUITING

Gartnavel General Hospital, Glasgow

Sponsors

Collaborators (1)

Medical Research Council
All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

collaborator

CRUK Trials unit Glasgow

UNKNOWN

lead

Lynn McMahon

OTHER